Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
399.80
+4.00 (1.01%)
At close: Feb 10, 2026
Swedish Orphan Biovitrum AB Employees
Swedish Orphan Biovitrum AB had 1,888 employees as of December 31, 2025. The number of employees increased by 82 or 4.54% compared to the previous year.
Employees
1,888
Change
82
Growth
4.54%
Revenue / Employee
14.96M SEK
Profits / Employee
253.18K SEK
Market Cap
136.81B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,888 | 82 | 4.54% |
| Sep 30, 2025 | 1,890 | 76 | 4.19% |
| Jun 30, 2025 | 1,937 | 165 | 9.31% |
| Mar 31, 2025 | 1,895 | 143 | 8.16% |
| Dec 31, 2024 | 1,806 | 66 | 3.79% |
| Sep 30, 2024 | 1,814 | 23 | 1.28% |
| Jun 30, 2024 | 1,772 | -21 | -1.17% |
| Mar 31, 2024 | 1,752 | 140 | 8.68% |
| Dec 31, 2023 | 1,740 | 184 | 11.83% |
| Sep 30, 2023 | 1,791 | 236 | 15.18% |
| Jun 30, 2023 | 1,793 | 239 | 15.38% |
| Mar 31, 2023 | 1,612 | 43 | 2.74% |
| Dec 31, 2022 | 1,556 | -3 | -0.19% |
| Sep 30, 2022 | 1,555 | 23 | 1.50% |
| Jun 30, 2022 | 1,554 | 17 | 1.11% |
| Mar 31, 2022 | 1,569 | 61 | 4.05% |
| Dec 31, 2021 | 1,559 | 50 | 3.31% |
| Sep 30, 2021 | 1,532 | 61 | 4.15% |
| Jun 30, 2021 | 1,537 | 115 | 8.09% |
| Mar 31, 2021 | 1,508 | 108 | 7.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioGaia AB | 238 |
| Orexo AB | 72 |
| EQL Pharma AB | 22 |
| Enzymatica AB | 21 |
| Cinclus Pharma Holding AB | 19 |
| Nanexa AB | 15 |
| Cereno Scientific AB | 10 |
| Moberg Pharma AB | 6 |
Swedish Orphan Biovitrum AB News
- 5 days ago - Swedish Orphan Biovitrum AB (publ) (SWOBY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Swedish Orphan Biovitrum AB (publ) 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 5 days ago - Swedish Orphan Biovitrum AB reports Q4 results - Seeking Alpha
- 25 days ago - European Commission Approves Sobi's Aspaveli for Rare Kidney Diseases - GuruFocus
- 26 days ago - SOBI: 2025 Revenue, Adj. EBITA Margin Higher Than Prior Guidance - Nasdaq
- 27 days ago - Swedish Orphan Biovitrum AB (publ) (SWOBY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Sobi Reports Positive Phase 2a EMBRACE Study Results For Gamifant In IFN?-Driven Sepsis - Nasdaq
- 2 months ago - Swedish Orphan Biovitrum AB (publ) (SWOBY) M&A Call Transcript - Seeking Alpha